Responses
Clinical/translational cancer immunotherapy
Original research
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Compose a Response to This Article
Other responses
No responses have been published for this article.
